Pilot Awards

MRA Pilot Awards test potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues.

To learn more about MRA funded research awards, please visit CureMelanoma.org/Grants

Overcoming Immunotherapy Resistance by Selective Inhibition of Notch1

MRA Pilot Award

Barbara Bedogni PhD, University of Miami, Miller School of Medicine

Imaging Biomarkers for Immunotherapy Resistance in Melanoma In Vivo

MRA Pilot Award

Pratip Bhattacharya PhD, University of Texas MD Anderson Cancer Center

Harnessing Proteasome Heterogeneity for Sensitization to Immunotherapy

MRA Pilot Award

Yifat Merbl PhD, Weizmann Institute of Science

Defining Mediators of Metastatic Spread in Acral Melanoma

MRA Pilot Award

Carla Daniela Robles-Espinoza PhD, Universidad Nacional
Autónoma de México

Dissecting the Impact of Noncoding Structural Variation in Melanoma Genomes

Leveraged Finance Fights Melanoma-MRA Pilot Award

Eliezer Van Allen MD, Dana-Farber Cancer Institute

Identifying and Targeting Melanoma Resident Macrophages

MRA Pilot Award

Andrew White PhD, Cornell University